PubMed:8430069
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 4-31 | protein | denotes | c-rel protooncogene product |
| T2 | 42-52 | protein | denotes | NF-kappa B |
| T3 | 53-56 | protein | denotes | p65 |
| T4 | 165-185 | DNA | denotes | long terminal repeat |
| T5 | 187-190 | DNA | denotes | LTR |
| T6 | 251-271 | DNA | denotes | 5' regulatory region |
| T7 | 297-333 | protein | denotes | interleukin 2 receptor alpha subunit |
| T8 | 335-346 | protein | denotes | IL-2R alpha |
| T9 | 365-390 | DNA | denotes | kappa B enhancer elements |
| T10 | 489-514 | DNA | denotes | kappa B enhancer elements |
| T11 | 601-604 | protein | denotes | p50 |
| T12 | 606-609 | protein | denotes | p65 |
| T13 | 634-653 | DNA | denotes | c-rel protooncogene |
| T14 | 655-660 | protein | denotes | c-Rel |
| T15 | 706-709 | protein | denotes | p65 |
| T16 | 714-717 | protein | denotes | p50 |
| T17 | 740-758 | protein | denotes | NF-kappa B complex |
| T18 | 954-963 | DNA | denotes | HIV-1 LTR |
| T19 | 971-991 | DNA | denotes | IL-2R alpha promoter |
| T20 | 1041-1044 | protein | denotes | p65 |
| T21 | 1098-1103 | protein | denotes | c-Rel |
| T22 | 1149-1176 | protein | denotes | tumor necrosis factor alpha |
| T23 | 1211-1214 | protein | denotes | p65 |
| T24 | 1235-1238 | protein | denotes | p65 |
| T25 | 1317-1322 | protein | denotes | c-Rel |
| T26 | 1411-1414 | protein | denotes | p50 |
| T27 | 1432-1437 | protein | denotes | c-Rel |
| T28 | 1475-1482 | protein | denotes | p50/p65 |
| T29 | 1584-1589 | protein | denotes | c-Rel |
| T30 | 1627-1636 | DNA | denotes | HIV-1 LTR |
| T31 | 1641-1652 | protein | denotes | IL-2R alpha |
| T32 | 1744-1747 | protein | denotes | p65 |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-160 | Sentence | denotes | The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus. |
| S2 | 161-482 | Sentence | denotes | The long terminal repeat (LTR) of the type 1 human immunodeficiency virus (HIV-1) and the 5' regulatory region of the gene encoding the interleukin 2 receptor alpha subunit (IL-2R alpha) share functional kappa B enhancer elements involved in the regulation of these inducible transcription units during T-cell activation. |
| S3 | 483-662 | Sentence | denotes | These kappa B enhancer elements are recognized by a structurally related family of interactive proteins that includes p50, p65, and the product of the c-rel protooncogene (c-Rel). |
| S4 | 663-849 | Sentence | denotes | Recent biochemical studies have shown that p65 and p50 form the prototypical NF-kappa B complex, which is rapidly translocated from the cytoplasm to the nucleus during T-cell activation. |
| S5 | 850-1045 | Sentence | denotes | This intracellular signaling complex potently stimulates kappa B-directed transcription from either the HIV-1 LTR or the IL-2R alpha promoter via the strong transactivation domain present in p65. |
| S6 | 1046-1288 | Sentence | denotes | We now demonstrate that nuclear expression of human c-Rel, which is induced by either phorbol ester or tumor necrosis factor alpha with delayed kinetics relative to p65, markedly represses p65-mediated activation of these transcription units. |
| S7 | 1289-1529 | Sentence | denotes | These inhibitory effects of c-Rel correlate with its DNA-binding activity but not with its ability to heterodimerize with p50, suggesting that c-Rel inhibition involves competition with p50/p65 for occupancy of the kappa B enhancer element. |
| S8 | 1530-1748 | Sentence | denotes | Together, these findings suggest that one function of c-Rel is as a physiologic repressor of the HIV-1 LTR and IL-2R alpha promoters, serving to efficiently counter the strong transcriptional activating effects of p65. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 0-31 | NP | denotes | The c-rel protooncogene product |
| C2 | 96-159 | NP | denotes | the long terminal repeat of type 1 human immunodeficiency virus |
| C4 | 161-242 | NP | denotes | The long terminal repeat (LTR) of the type 1 human immunodeficiency virus (HIV-1) |
| C6 | 293-347 | NP | denotes | the interleukin 2 receptor alpha subunit (IL-2R alpha) |
| C5 | 247-347 | NP | denotes | the 5' regulatory region of the gene encoding the interleukin 2 receptor alpha subunit (IL-2R alpha) |
| C3 | 161-347 | NP | denotes | The long terminal repeat (LTR) of the type 1 human immunodeficiency virus (HIV-1) and the 5' regulatory region of the gene encoding the interleukin 2 receptor alpha subunit (IL-2R alpha) |
| C8 | 421-456 | NP | denotes | these inducible transcription units |
| C9 | 464-481 | NP | denotes | T-cell activation |
| C7 | 354-481 | NP | denotes | functional kappa B enhancer elements involved in the regulation of these inducible transcription units during T-cell activation |
| C10 | 483-514 | NP | denotes | These kappa B enhancer elements |
| C11 | 533-586 | NP | denotes | a structurally related family of interactive proteins |
| C12 | 587-591 | NP | denotes | that |
| C13 | 601-604 | NP | denotes | p50 |
| C14 | 606-609 | NP | denotes | p65 |
| C16 | 630-661 | NP | denotes | the c-rel protooncogene (c-Rel) |
| C15 | 615-661 | NP | denotes | the product of the c-rel protooncogene (c-Rel) |
| C17 | 706-709 | NP | denotes | p65 |
| C18 | 714-717 | NP | denotes | p50 |
| C19 | 723-758 | NP | denotes | the prototypical NF-kappa B complex |
| C20 | 760-765 | NP | denotes | which |
| C21 | 831-848 | NP | denotes | T-cell activation |
| C22 | 850-886 | NP | denotes | This intracellular signaling complex |
| C23 | 950-963 | NP | denotes | the HIV-1 LTR |
| C25 | 971-982 | NP | denotes | IL-2R alpha |
| C24 | 967-991 | NP | denotes | the IL-2R alpha promoter |
| C26 | 1041-1044 | NP | denotes | p65 |
| C28 | 1092-1103 | NP | denotes | human c-Rel |
| C27 | 1070-1103 | NP | denotes | nuclear expression of human c-Rel |
| C29 | 1105-1110 | NP | denotes | which |
| C30 | 1211-1214 | NP | denotes | p65 |
| C31 | 1262-1287 | NP | denotes | these transcription units |
| C32 | 1317-1322 | NP | denotes | c-Rel |
| C33 | 1338-1341 | NP | denotes | its |
| C34 | 1376-1379 | NP | denotes | its |
| C35 | 1411-1414 | NP | denotes | p50 |
| C36 | 1432-1437 | NP | denotes | c-Rel |
| C37 | 1475-1478 | NP | denotes | p50 |
| C38 | 1479-1482 | NP | denotes | p65 |
| C39 | 1500-1528 | NP | denotes | the kappa B enhancer element |
| C40 | 1584-1589 | NP | denotes | c-Rel |
| C41 | 1627-1636 | NP | denotes | HIV-1 LTR |
| C43 | 1641-1652 | NP | denotes | IL-2R alpha |
| C42 | 1641-1662 | NP | denotes | IL-2R alpha promoters |
| C44 | 1744-1747 | NP | denotes | p65 |
| R1 | C4 | C2 | coref-ident | The long terminal repeat (LTR) of the type 1 human immunodeficiency virus (HIV-1),the long terminal repeat of type 1 human immunodeficiency virus |
| R2 | C8 | C3 | coref-other | these inducible transcription units,The long terminal repeat (LTR) of the type 1 human immunodeficiency virus (HIV-1) and the 5' regulatory region of the gene encoding the interleukin 2 receptor alpha subunit (IL-2R alpha) |
| R3 | C10 | C7 | coref-ident | These kappa B enhancer elements,functional kappa B enhancer elements involved in the regulation of these inducible transcription units during T-cell activation |
| R4 | C12 | C11 | coref-relat | that,a structurally related family of interactive proteins |
| R5 | C15 | C1 | coref-ident | the product of the c-rel protooncogene (c-Rel),The c-rel protooncogene product |
| R6 | C17 | C14 | coref-ident | p65,p65 |
| R7 | C18 | C13 | coref-ident | p50,p50 |
| R8 | C20 | C19 | coref-relat | which,the prototypical NF-kappa B complex |
| R9 | C21 | C9 | coref-ident | T-cell activation,T-cell activation |
| R10 | C22 | C19 | coref-ident | This intracellular signaling complex,the prototypical NF-kappa B complex |
| R11 | C23 | C4 | coref-ident | the HIV-1 LTR,The long terminal repeat (LTR) of the type 1 human immunodeficiency virus (HIV-1) |
| R12 | C25 | C6 | coref-ident | IL-2R alpha,the interleukin 2 receptor alpha subunit (IL-2R alpha) |
| R13 | C24 | C5 | coref-other | the IL-2R alpha promoter,the 5' regulatory region of the gene encoding the interleukin 2 receptor alpha subunit (IL-2R alpha) |
| R14 | C26 | C17 | coref-ident | p65,p65 |
| R15 | C28 | C16 | coref-other | human c-Rel,the c-rel protooncogene (c-Rel) |
| R16 | C29 | C27 | coref-relat | which,nuclear expression of human c-Rel |
| R17 | C30 | C26 | coref-ident | p65,p65 |
| R18 | C31 | C8 | coref-ident | these transcription units,these inducible transcription units |
| R19 | C32 | C28 | coref-other | c-Rel,human c-Rel |
| R20 | C33 | C32 | coref-pron | its,c-Rel |
| R21 | C34 | C32 | coref-pron | its,c-Rel |
| R22 | C35 | C18 | coref-ident | p50,p50 |
| R23 | C36 | C32 | coref-ident | c-Rel,c-Rel |
| R24 | C37 | C35 | coref-ident | p50,p50 |
| R25 | C38 | C30 | coref-ident | p65,p65 |
| R26 | C39 | C10 | coref-other | the kappa B enhancer element,These kappa B enhancer elements |
| R27 | C40 | C36 | coref-ident | c-Rel,c-Rel |
| R28 | C41 | C23 | coref-ident | HIV-1 LTR,the HIV-1 LTR |
| R29 | C43 | C25 | coref-ident | IL-2R alpha,IL-2R alpha |
| R30 | C42 | C24 | coref-ident | IL-2R alpha promoters,the IL-2R alpha promoter |
| R31 | C44 | C38 | coref-ident | p65,p65 |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 4-23 | DNA_domain_or_region | denotes | c-rel protooncogene |
| T2 | 42-52 | protein_molecule | denotes | NF-kappa B |
| T3 | 53-56 | protein_subunit | denotes | p65 |
| T4 | 66-92 | other_name | denotes | transcriptional activation |
| T5 | 131-159 | virus | denotes | human immunodeficiency virus |
| T6 | 165-185 | DNA_domain_or_region | denotes | long terminal repeat |
| T7 | 187-190 | DNA_domain_or_region | denotes | LTR |
| T8 | 199-205 | virus | denotes | type 1 |
| T9 | 206-234 | virus | denotes | human immunodeficiency virus |
| T10 | 236-241 | virus | denotes | HIV-1 |
| T11 | 251-271 | DNA_domain_or_region | denotes | 5' regulatory region |
| T12 | 297-333 | protein_subunit | denotes | interleukin 2 receptor alpha subunit |
| T13 | 335-346 | protein_subunit | denotes | IL-2R alpha |
| T14 | 365-390 | DNA_domain_or_region | denotes | kappa B enhancer elements |
| T15 | 464-481 | other_name | denotes | T-cell activation |
| T16 | 489-514 | DNA_domain_or_region | denotes | kappa B enhancer elements |
| T17 | 601-604 | protein_molecule | denotes | p50 |
| T18 | 606-609 | protein_molecule | denotes | p65 |
| T19 | 634-653 | DNA_domain_or_region | denotes | c-rel protooncogene |
| T20 | 655-660 | protein_molecule | denotes | c-Rel |
| T21 | 706-709 | protein_molecule | denotes | p65 |
| T22 | 714-717 | protein_molecule | denotes | p50 |
| T23 | 740-750 | protein_molecule | denotes | NF-kappa B |
| T24 | 799-808 | cell_component | denotes | cytoplasm |
| T25 | 816-823 | cell_component | denotes | nucleus |
| T26 | 831-848 | other_name | denotes | T-cell activation |
| T27 | 907-937 | other_name | denotes | kappa B-directed transcription |
| T28 | 954-963 | DNA_domain_or_region | denotes | HIV-1 LTR |
| T29 | 971-982 | protein_molecule | denotes | IL-2R alpha |
| T30 | 1041-1044 | protein_molecule | denotes | p65 |
| T31 | 1098-1103 | protein_molecule | denotes | c-Rel |
| T32 | 1132-1145 | other_organic_compound | denotes | phorbol ester |
| T33 | 1149-1176 | protein_molecule | denotes | tumor necrosis factor alpha |
| T34 | 1211-1214 | protein_subunit | denotes | p65 |
| T35 | 1235-1238 | protein_molecule | denotes | p65 |
| T36 | 1317-1322 | protein_molecule | denotes | c-Rel |
| T37 | 1342-1362 | other_name | denotes | DNA-binding activity |
| T38 | 1411-1414 | protein_molecule | denotes | p50 |
| T39 | 1432-1437 | protein_molecule | denotes | c-Rel |
| T40 | 1475-1478 | protein_molecule | denotes | p50 |
| T41 | 1478-1482 | protein_molecule | denotes | /p65 |
| T42 | 1584-1589 | protein_molecule | denotes | c-Rel |
| T43 | 1627-1636 | DNA_domain_or_region | denotes | HIV-1 LTR |
| T44 | 1641-1652 | protein_molecule | denotes | IL-2R alpha |
| T45 | 1744-1747 | protein_molecule | denotes | p65 |